Description

Drug Classification:

Iron Isomaltoside Injection belongs to the class of drugs known as iron supplements. This formulation delivers a highly bioavailable form of iron, ensuring rapid and effective correction of iron deficiency anemia.

Formulations:

• Iron Isomaltoside Injection:
  • Strength: Each liquid ampule contains 100 mg of Iron (as Iron Isomaltoside).
  • Product Form: Injectable solution for intravenous administration.
  • Packing Specs: Available in packs of 5 liquid ampoules for convenient dosing and storage.

Indications:

Iron Isomaltoside Injection is indicated for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron preparations or who have a clinical need for rapid iron repletion. This product is particularly beneficial for individuals with chronic diseases such as inflammatory bowel disease, chronic kidney disease, or heart failure, where oral iron absorption may be impaired or insufficient to meet iron requirements.

Usage:

• Iron Isomaltoside Injection should be administered under the supervision of a healthcare professional experienced in the management of iron deficiency anemia.
• The injection is intended for intravenous use only and should not be administered via other routes.
• Prior to administration, the liquid ampule should be visually inspected for particulate matter and discoloration. Any ampules showing signs of contamination should not be used.
• The injection should be administered at the recommended rate of infusion to minimize the risk of adverse reactions.

Dosage:

• The recommended dosage of Iron Isomaltoside Injection is determined based on the patient’s iron deficit and hemoglobin levels, as well as their clinical response to treatment.
• Dosage adjustments may be necessary for patients with severe iron deficiency anemia or underlying medical conditions affecting iron metabolism.

Pharmacokinetics:

• Iron Isomaltoside is a stable, water-soluble complex of iron and isomaltoside, designed to facilitate the controlled release of iron into the bloodstream.
• Following intravenous administration, Iron Isomaltoside undergoes rapid dissociation, releasing iron ions that bind to transferrin and are transported to the bone marrow for incorporation into hemoglobin.

Pharmacodynamics:

• Iron Isomaltoside Injection replenishes iron stores and supports erythropoiesis, leading to an increase in hemoglobin levels and resolution of iron deficiency anemia.
• The controlled release of iron from the isomaltoside complex minimizes the risk of adverse effects associated with rapid iron infusion, such as hypotension or hypersensitivity reactions.

Side Effects:

• Common side effects associated with Iron Isomaltoside Injection may include transient gastrointestinal disturbances, such as nausea, vomiting, or abdominal discomfort.
• Hypersensitivity reactions, including anaphylaxis, may occur rarely following intravenous administration of iron preparations. Patients should be monitored closely for signs of allergic reactions during and after infusion.

Trust in the efficacy and safety of Iron Isomaltoside Injection from AIT Pharmaceuticals Division. With our commitment to quality and patient care, we strive to deliver pharmaceutical products that make a meaningful difference in the lives of individuals affected by iron deficiency anemia. For more information, please visit our website or consult your healthcare provider.